Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring of Immune and Microbial Reconstitution in Hematopoietic Cell Transplantation (HCT) and Novel Immunotherapies

NCT03557749 is registered in ClinicalTrials.gov with Masonic Cancer Center, University of Minnesota as lead sponsor.

NCT NCT03557749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03557749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring of Immune and Microbial Reconstitution in Hematopoietic Cell Transplantation (HCT) and Novel Immunotherapies
Lead sponsor
Masonic Cancer Center, University of Minnesota
Phase
Observational
Overall status
Terminated
Start date
September 21, 2018
Completion date
August 15, 2023
Enrollment
210 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute-graft-versus-host disease, allogenic related donors, cell therapy/immunotherapy patients, chronic graft-versus-host-disease, cytokine release syndrome, immune and microbial reconstitution, recurrent malignancy, systemic viral infection